SGLT2 inhibitor benefits patients with HFpEF by reducing clinically meaningful CV events
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Prof. Barbara Casadei, MD
Prof. Bruce Neal, MD, PhD
Prof Bertram Pitt
Prof. Frank Ruschitzka, MD